Back to User profile » Dr Samuel Stoddart
Paper published by Dr Samuel Stoddart:
Original Research
![Noteworthy comment: In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. Acceptance of submissions with higher-than-threshold ICERs varied by HTA agency and was not significantly influenced by disease category. Such submissions must be accompanied by robust, concrete, and transparent evidence in order to achieve patient access.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold
Griffiths EA, Hendrich JK, Stoddart SDR, Walsh SCM
ClinicoEconomics and Outcomes Research 2015, 7:463-476
Published Date: 31 August 2015